Clinical Trials for Effectiveness of Combination Therapy using Ezetimibe and Rosuvastatin/Atorvastatin
Phase of Trial: Phase II
Latest Information Update: 10 Mar 2011
At a glance
- Drugs Ezetimibe (Primary) ; Atorvastatin; Rosuvastatin
- Indications Coronary artery disease; Hyperlipidaemia
- Focus Biomarker; Pharmacodynamics; Therapeutic Use
- Acronyms CTE2RA
- 10 Mar 2011 Status changed from active, no longer recruiting to completed.
- 10 Dec 2010 Planned End Date changed from 1 Sep 2010 to 1 Jan 2011 as reported by University Hospital Medical Information Network - Japan record.
- 10 Dec 2010 Status changed from recruiting to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan record.